NeoGenomics, Inc. (NEO)
11.44
+0.49
(+4.47%)
USD |
NASDAQ |
Jun 09, 16:00
11.44
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics SG&A Expense (Quarterly) : 89.57M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| OPKO Health, Inc. | 48.61M |
| Quest Diagnostics, Inc. | 504.00M |
| Labcorp Holdings, Inc. | 551.00M |
| Psychemedics Corp. | -- |
| First Choice Healthcare Solutions, Inc. | 0.3629M |